What is SeqOnce BioScience?
SeqOnce BioScience is a biotechnology firm dedicated to advancing genomics research through the development of rapid and efficient qPCR and library preparation kits. Their product suite is engineered to enhance throughput and deliver faster results for researchers in the genomics field. The company distinguishes itself through a strong commitment to technical assistance and responsive customer service, ensuring comprehensive support for its clientele.
SeqOnce's focus on innovation extends to conservation, utilizing their assays and reagents to aid in the protection of endangered species.
How much funding has SeqOnce BioScience raised?
SeqOnce BioScience has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2018): $1M, investors not publicly disclosed
What's next for SeqOnce BioScience?
With the recent major strategic investment, SeqOnce BioScience is poised to expand its operational capabilities and further refine its product offerings. The enterprise-level funding suggests a strategic phase focused on scaling production, enhancing market reach, and potentially exploring new applications for their advanced genomics technologies. Future developments are likely to center on solidifying their position as a key provider of high-throughput solutions in the competitive bioscience landscape.
See full SeqOnce BioScience company page
